Radio and PodcastRadio and PodcastLive Radio & Podcasts
JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma artwork
Science & Medicine

JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma

Journal of Clinical Oncology (JCO) Podcast by Journals Online Team

Jun 1, 202610:28Science & Medicine

JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2026 Simultaneous Publication paper " Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Re...

About This Episode

JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma is an episode from Journal of Clinical Oncology (JCO) Podcast by Journals Online Team. JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. G...

Podcast

This episode belongs to Journal of Clinical Oncology (JCO) Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 1, 2026, 10:28 long, audio available.

Related Episodes

Continue listening to more episodes from Journal of Clinical Oncology (JCO) Podcast.